SightfileU.S. market data from official filings

PULMONX CORP (LUNG)

Name: PULMONX CORP (LUNG) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001127537 · EDGAR filings · Updated 2026-06-09

PULMONX CORP (LUNG) has reported institutional ownership of 75.2%, with 113 institutional managers holding positions valued at $41.0M per the latest 13F reporting period.

Institutional ownership

75.2%

Institutional managers

113

Reported 13F value

$41.0M

Insider activity

66 trans.

−$345.7K net selling

Latest updates

2026-06-09 — Insider transaction reported (Form 4)
2026-06-09 — Insider transaction reported (Form 4)
2026-06-09 — Insider transaction reported (Form 4)
2026-06-09 — Insider transaction reported (Form 4)
2026-06-09 — Insider transaction reported (Form 4)
2026-06-09 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, PULMONX CORP has 113 institutional holders and institutional ownership of 75.2%.

Insider activity

Insiders reported 66 transactions (1 buys, 53 sells) across 13 reporting insiders, with a net reported value of −$345.7K.

Related companies

SATELLOS BIOSCIENCE INC (MSLE) · Rallybio Corp (RLYB) · GREENWICH LIFESCIENCES INC (GLSI) · LUCID DIAGNOSTICS INC (LUCD) · NANO X IMAGING LTD (NNOX) · PYXIS ONCOLOGY INC (PYXS)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-09.